REQUEST A DEMO
Total
USD $0.00
Search more companies

Shalman Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Shalman Pharmaceuticals Private Limited Profile Updated: December 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Shalman Pharmaceuticals Private Limited is an unlisted company, incorporated on 29/06/1994. It has its registered office in the State of Gujarat, India. Company's corporate identification number (CIN) is U24231GJ1994PTC022380 and registration number is 022380. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
27/B Sahajanad Industrialestate Muzmavda Baroda Gj 000000 In
Vadodara; Gujarat;

Contact Details: Purchase the Shalman Pharmaceuticals Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Shalman Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Shalman Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
June 29, 1994
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Shalman Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.59%
Total operating revenue
-2.6%
Operating profit (EBIT)
50.96%
EBITDA
44.28%
Net Profit (Loss) for the Period
13.26%
Total Assets
18.9%
Total Equity
10.57%
Operating Profit Margin (ROS)
2.45%
Net Profit Margin
0.44%
Return on Equity (ROE)
0.23%
Debt/Equity
43.26%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?